[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366789-105":59,"doc-detail-366789-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","integrative-analysis-identifies-tead4-as-a-universal-prognostic-biomarker-in-human-cancers","Integrative analysis identifies TEAD4 as a universal prognostic biomarker in human cancers","","Integrative analysis evaluates TEAD4 across multiple human tumor types, focusing on expression patterns, prognostic value, and potential therapeutic relevance. Using publicly available datasets (including TCGA), the study assesses gene expression profiles, survival associations, functional enrichment, and drug sensitivity, complemented by in vitro experiments. Results show TEAD4 is overexpressed in several cancers and links to unfavorable outcomes, tumor proliferation, metastasis, cancer stemness, immune regulation, genomic instability, and resistance to multiple chemotherapeutic agents. A TEAD4-target gene expression model stratifies patients by survival risk.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-analysis-identifies-tead4-as-a-universal-prognostic-biomarker-in-human-cancers/366789/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-analysis-identifies-tead4-as-a-universal-prognostic-biomarker-in-human-cancers/366789.png","ImageObject",300,407,{"name":92,"@type":93},"Anna Hans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study identify about TEAD4 in human cancers?","Question",{"text":112,"@type":113},"TEAD4 is found to be significantly overexpressed across multiple cancers and associated with unfavorable patient prognosis. The work positions TEAD4 as a universal prognostic biomarker and therapeutic target.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was TEAD4 analyzed across tumor types?",{"text":117,"@type":113},"The study used publicly available datasets, including TCGA, to evaluate TEAD4 expression, prognostic correlations, functional enrichment, and drug sensitivity. In vitro assays were also performed to validate TEAD4’s roles.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional effects does TEAD4 have in cancer cell behavior?",{"text":121,"@type":113},"In vitro experiments show TEAD4 promotes proliferation, migration, and stem cell-like properties. TEAD4 knockdown reverses these phenotypes.",{"name":123,"@type":110,"acceptedAnswer":124},"How does TEAD4 relate to therapy response and survival risk?",{"text":125,"@type":113},"Higher TEAD4 levels correlate with resistance to several chemotherapeutic agents. A prognostic model built on TEAD4 target gene expression stratifies patients by survival risk.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},366789,1791334707,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},5909892332657,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","TYPE Original Research PUBLISHED 30 September 2025 DOI 10.3389/fimmu.2025.1688563  \nOPEN ACCESS  \nEDITED BY  \nXiaosheng Tan,  \nRutgers, The State University of New Jersey, United States  \nREVIEWED BY  \nFeifei Song,  \nUniversity of North Carolina at Chapel Hill, United States  \nQi Wang,  \nAuburn University, United States Shasha Lyu,  \nCornell University, United States Chunyu Wei,  \nUniversity of Maryland, Baltimore, United States  \n*CORRESPONDENCE  \nYi Jin  \n[jinyi200911@163.com](jinyi200911@163.com)[ ](jinyi200911@163.com)Chang Liu  \n [Liuchangcmu@163.com](Liuchangcmu@163.com)[ ](Liuchangcmu@163.com)Biao Wang  \n[wangbiao@cmu.edu.cn](wangbiao@cmu.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 19 August 2025  \nACCEPTED 15 September 2025  \nPUBLISHED 30 September 2025  \nCITATION  \nLiu M, Song Y, Kang Y, Xue N, Zhao J, Jin Y, Liu C and Wang B (2025) Integrative analysis identiﬁes TEAD4 as a universal prognostic biomarker in human cancers.  \nFront. Immunol. 16:1688563 .  \ndoi: 10.3389/fimmu.2025.1688563  \nCOPYRIGHT  \n© 2025 Liu, Song, Kang, Xue, Zhao, Jin, Liu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nIntegrative analysis identiﬁes TEAD4 as a universal prognostic biomarker in human cancers  \nMohan Liu 1†, Yang Song 2†, Yue Kang 3†, Nan Xue 4†, Jiuhan Zhao 5†, Yi Jin 3*, Chang Liu 6* and Biao Wang 1*  \n1 Department of Biochemistry and Molecular Biology, School of Life Sciences, China Medical University, Shenyang, China, 2Geriatrics Center, Fourth People’s Hospital of Shenyang,  \nShenyang, China, 3 Department of Breast Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China, 4 Department of Orthodontics, School and Hospital of Stomatology of China Medical University, Liaoning Provincial Key Laboratory of Oral Disease, Shenyang, China, 5 Department of Neurology, The First Afﬁliated Hospital of China Medical University, Shenyang, Liaoning, China, 6 Department of Radiation Oncology, The First Afﬁliated Hospital of China Medical University, Shenyang, China  \nIntroduction: TEA domain transcription factor 4 (TEAD4), a key effector of the Hippo signaling pathway, has been increasingly associated with tumorigenesis and cancer progression. Despite its recognized role, comprehensive pan-cancer analyses of TEAD4 expression patterns, prognostic signiﬁcance, and therapeutic implications remain scarce.  \nMethods: We conducted a systematic evaluation of TEAD4 across diverse tumor types using publicly available datasets, including TCGA. Analyses included gene expression proﬁling, prognostic correlation, functional enrichment, and drug sensitivity assessments. Additionally, in vitro assays were performed to validate the functional roles of TEAD4 in cancer cell behavior.  \nResults: TEAD4 was signiﬁcantly overexpressed in multiple cancers and associated with unfavorable prognosis. Functional enrichment analyses implicated TEAD4 in oncogenic processes such as proliferation, metastasis, stem ness maintenance, and immune regulation . In vitro experiments conﬁrmed that TEAD4 promotes cancer cell proliferation, migration, and stem cell-like properties, while TEAD4 knockdown reversed these phenotypes. TEAD4 expression correlated with genomic instability, epigenetic alterations, andremodeling of the tumor microenvironment. Drug sensitivity analysis indicated that elevated TEAD4 levels were linked to resistance against several chemotherapeutic agents. Furthermore, a prognostic model based on TEAD4 target gene expression ","cbCairBRakK9ki3q","https://ap.wps.com/l/cbCairBRakK9ki3q","pdf",56694983,28,"English","# Highlights\n## Universal prognostic biomarker\n## In vitro functional validation\n## Multi-omics immune microenvironment remodeling\n## TEAD4-based gene signature\n## Precision oncology therapeutic target\n# 1 Introduction\n## Clinical challenge of resistance and recurrence\n## Need for robust prognostic biomarkers\n# Methods\n## Systematic evaluation using public datasets (TCGA)\n## Gene expression, prognostic correlation, enrichment, and drug sensitivity\n## In vitro validation of TEAD4 functions\n# Results\n## TEAD4 overexpression and unfavorable prognosis\n## Oncogenic functional roles and phenotypic effects\n## Correlations with genomic instability and tumor microenvironment\n## Drug resistance associations and prognostic model","[{\"question\":\"What does the study identify about TEAD4 in human cancers?\",\"answer\":\"TEAD4 is found to be significantly overexpressed across multiple cancers and associated with unfavorable patient prognosis. The work positions TEAD4 as a universal prognostic biomarker and therapeutic target.\"},{\"question\":\"How was TEAD4 analyzed across tumor types?\",\"answer\":\"The study used publicly available datasets, including TCGA, to evaluate TEAD4 expression, prognostic correlations, functional enrichment, and drug sensitivity. In vitro assays were also performed to validate TEAD4’s roles.\"},{\"question\":\"What functional effects does TEAD4 have in cancer cell behavior?\",\"answer\":\"In vitro experiments show TEAD4 promotes proliferation, migration, and stem cell-like properties. TEAD4 knockdown reverses these phenotypes.\"},{\"question\":\"How does TEAD4 relate to therapy response and survival risk?\",\"answer\":\"Higher TEAD4 levels correlate with resistance to several chemotherapeutic agents. A prognostic model built on TEAD4 target gene expression stratifies patients by survival risk.\"}]","Integrative analysis identifies TEAD4 as a universal prognostic biomarker in human cancers | PDF",1790167441,71,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/832627969f1ddaf2e6389f816029a55d.webp",983,1389,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3e665313770f3327930b8db8abe28b3.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99d0b6afcc60448c335bf709b18d2ea6.webp",981,1387,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/180ec707d56bd5e608dcbc33e077b5ee.webp",980,1385]